Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap

[1]  J. Soriano,et al.  ACO: Time to move from the description of different phenotypes to the treatable traits , 2019, PloS one.

[2]  M. Miravitlles,et al.  Practical Guide to the Identification and Diagnosis of Asthma-COPD Overlap (ACO) , 2019, COPD.

[3]  W. Kim,et al.  Differences in prevalence of asthma–COPD overlap according to different criteria , 2018, Medicine.

[4]  Meilan K. Han,et al.  Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD , 2018, The New England journal of medicine.

[5]  N. Roche,et al.  Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial , 2018, The Lancet.

[6]  S. Rennard,et al.  Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. , 2018, The Lancet. Respiratory medicine.

[7]  M. Miravitlles,et al.  Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease. , 2017, Archivos de bronconeumologia.

[8]  J. Soriano,et al.  Asthma-COPD overlap is not a homogeneous disorder: further supporting data , 2017, Respiratory Research.

[9]  J. Soriano,et al.  Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD , 2017, European Respiratory Journal.

[10]  T. H. Nguyen,et al.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.

[11]  Chang-Hoon Lee,et al.  Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD , 2017, International journal of chronic obstructive pulmonary disease.

[12]  M. Miravitlles,et al.  Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study , 2017, International journal of chronic obstructive pulmonary disease.

[13]  M. Miravitlles,et al.  Consensus on the Asthma–COPD Overlap (ACO) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA) , 2017 .

[14]  M. Miravitlles,et al.  Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). , 2017, Archivos de bronconeumologia.

[15]  Pere Almagro,et al.  Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable , 2017 .

[16]  J. Soriano,et al.  Th-2 signature in chronic airway diseases: towards the extinction of asthma−COPD overlap syndrome? , 2017, European Respiratory Journal.

[17]  H. Makita,et al.  Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study. , 2016, American journal of respiratory and critical care medicine.

[18]  D. Price,et al.  What is asthma−COPD overlap syndrome? Towards a consensus definition from a round table discussion , 2016, European Respiratory Journal.

[19]  J. Vestbo,et al.  Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. , 2016, The Lancet. Respiratory medicine.

[20]  B. Nordestgaard,et al.  Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. , 2016, American journal of respiratory and critical care medicine.

[21]  P. Calverley,et al.  Blood eosinophils as a marker of response to inhaled corticosteroids in COPD , 2016, European Respiratory Journal.

[22]  R. Louis,et al.  Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD , 2016, European Respiratory Journal.

[23]  J. Soriano,et al.  Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. , 2016, Chest.

[24]  N. Barnes,et al.  Understanding asthma-chronic obstructive pulmonary disease overlap syndrome. , 2016, Respiratory medicine.

[25]  I. Pavord,et al.  Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD , 2015, Thorax.

[26]  J. Wedzicha,et al.  Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory and critical care medicine.

[27]  I. Pavord,et al.  Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. , 2015, The Lancet. Respiratory medicine.

[28]  D. Postma,et al.  Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. , 2015, American journal of respiratory and critical care medicine.

[29]  V. Moral.  GEMA4.0. Guía española para el manejo del asma , 2015 .

[30]  G. Valdivia,et al.  Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. , 2014, Chest.

[31]  J. Soriano,et al.  Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. , 2013, Respiratory medicine.

[32]  P. Casán,et al.  Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). , 2013, Archivos de bronconeumologia.

[33]  R. de Marco,et al.  The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population , 2013, PloS one.

[34]  José Raúl Rodríguez Rodríguez,et al.  Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC , 2012 .

[35]  Christopher E Brightling,et al.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.

[36]  T. Haahtela,et al.  Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[37]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[38]  J. Jácome.  Guía Española para el Manejo del Asma (GEMA) , 2005 .

[39]  Philip Marcus,et al.  Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.

[40]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.